{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:21:58Z","timestamp":1780633318811,"version":"3.54.1"},"reference-count":31,"publisher":"Zhejiang University Press","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Zhejiang Provincial Natural Science Foundation of China","award":["LY15H150004"],"award-info":[{"award-number":["LY15H150004"]}]},{"name":"the Teaching Department of the Zhejiang Province , China","award":["Y201330073"],"award-info":[{"award-number":["Y201330073"]}]}],"content-domain":{"domain":["springerlink.com","jzus.zju.edu.cn"],"crossmark-restriction":true},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1631\/jzus.b1700052","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T14:06:01Z","timestamp":1512655561000},"page":"994-1001","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Endostatin inhibits fibrosis by modulating the PDGFR\/ERK signal pathway: an in vitro study","\u5185\u76ae\u6291\u7d20\u901a\u8fc7\u8c03\u63a7PDGFR\/ERK\u4fe1\u53f7\u901a\u8def\u6291\u5236\u4eba\u6210\u7ea4\u7ef4\u7ec6\u80de\u7ea4\u7ef4\u5316\u7684\u7814\u7a76"],"prefix":"10.1631","volume":"18","author":[{"given":"Yuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2588-9523","authenticated-orcid":false,"given":"Hai-tao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"635","published-online":{"date-parts":[[2017,11,12]]},"reference":[{"issue":"10","key":"271_CR1","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","volume":"22","author":"J. Andrae","year":"2008","unstructured":"Andrae, J., Gallini, R., Betsholtz, C., 2008. Role of plateletderived growth factors in physiology and medicine. Gene Dev., 22(10):1276\u20131312. http:\/\/dx.doi.org\/10.1101\/gad.1653708","journal-title":"Gene Dev."},{"key":"271_CR2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.12688\/f1000research.8190.1","volume":"5","author":"M.L. Bochaton-Piallat","year":"2016","unstructured":"Bochaton-Piallat, M.L., Gabbiani, G., Hinz, B., 2016. The myofibroblast in wound healing and fibrosis: answered and unanswered questions. F1000Research, 5:752. http:\/\/dx.doi.org\/10.12688\/f1000research.8190.1","journal-title":"F1000Research"},{"issue":"4","key":"271_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","volume":"15","author":"J.C. Bonner","year":"2004","unstructured":"Bonner, J.C., 2004. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth F. R., 15(4):255\u2013273. http:\/\/dx.doi.org\/10.1016\/j.cytogfr.2004.03.006","journal-title":"Cytokine Growth F. R."},{"key":"271_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cytogfr.2015.10.002","volume":"28","author":"E. Borkham-Kamphorst","year":"2015","unstructured":"Borkham-Kamphorst, E., Weiskirchen, R., 2015. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev., 28:53-61. http:\/\/dx.doi.org\/10.1016\/j.cytogfr.2015.10.002","journal-title":"Cytokine Growth Factor Rev."},{"issue":"9","key":"271_CR5","doi-asserted-by":"crossref","first-page":"e0162758","DOI":"10.1371\/journal.pone.0162758","volume":"11","author":"J.S. Cho","year":"2016","unstructured":"Cho, J.S., Fang, T.C., Reynolds, T.L., et al., 2016. PDGF-BB promotes type I IFN-dependent vascular alterations and monocyte recruitment in a model of dermal fibrosis. PLoS ONE, 11(9):e0162758. http:\/\/dx.doi.org\/10.1371\/journal.pone.0162758","journal-title":"PLoS ONE"},{"issue":"2","key":"271_CR6","doi-asserted-by":"crossref","first-page":"e0149266","DOI":"10.1371\/journal.pone.0149266","volume":"11","author":"H.I. Choi","year":"2016","unstructured":"Choi, H.I., Ma, S.K., Bae, E.H., et al., 2016. Peroxiredoxin 5 protects TGF-\u00df induced fibrosis by inhibiting Stat3 activation in rat kidney interstitial fibroblast cells. PLoS ONE, 11(2):e0149266. http:\/\/dx.doi.org\/10.1371\/journal.pone.0149266","journal-title":"PLoS ONE"},{"issue":"10","key":"271_CR7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/labinvest.2008.71","volume":"88","author":"B.K. Erawan","year":"2008","unstructured":"Erawan, B.K., Evgenia, K., Roeyen, C.R.C., et al., 2008. Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury. Lab. Invest., 88(10):1090\u20131100. http:\/\/dx.doi.org\/10.1038\/labinvest.2008.71","journal-title":"Lab. Invest."},{"issue":"3","key":"271_CR8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.taap.2013.08.009","volume":"272","author":"L. Fang","year":"2013","unstructured":"Fang, L., Zhan, S., Huang, C., et al., 2013. TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways. Toxicol. Appl. Pharmacol., 272(3):713\u2013725. http:\/\/dx.doi.org\/10.1016\/j.taap.2013.08.009","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"271_CR9","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1097\/SAP.0000000000000103","volume":"72","author":"J.S. Friedstat","year":"2014","unstructured":"Friedstat, J.S., Hultman, C.S., 2014. Hypertrophic burn scar management: what does the evidence show? A systematic review of randomized controlled trials. Ann. Plastic Surg., 72(6): S198\u2013S201. http:\/\/dx.doi.org\/10.1097\/SAP.0000000000000103","journal-title":"Ann. Plastic Surg."},{"issue":"4","key":"271_CR10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/1523-1747.ep12396856","volume":"103","author":"M. Haisa","year":"1994","unstructured":"Haisa, M., Okochi, H., Grotendorst, G.R., 1994. Elevated levels of PDGF a receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J. Invest. Dermatol., 103(4):560\u2013563. http:\/\/dx.doi.org\/10.1111\/1523-1747.ep12396856","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"271_CR11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/abbi.2001.2707","volume":"398","author":"C.H. Heldin","year":"2002","unstructured":"Heldin, C.H., Eriksson, U., \u00d6stman, A., 2002. New members of the platelet-derived growth factor family of mitogens. Arch. Biochem. Biophys., 398(2):284\u2013290. http:\/\/dx.doi.org\/10.1006\/abbi.2001.2707","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"271_CR12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3892\/ijmm.2012.1110","volume":"30","author":"J.G. Hu","year":"2012","unstructured":"Hu, J.G., Wu, X.J., Feng, Y.F., et al., 2012. PDGF-AA and bFGF mediate B104CM-induced proliferation of oligodendrocyte precursor cells. Int. J. Mol. Med., 30(5): 1113\u20131118. http:\/\/dx.doi.org\/10.3892\/ijmm.2012.1110","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"271_CR13","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1172\/JCI24652","volume":"116","author":"M. Jechlinger","year":"2006","unstructured":"Jechlinger, M., Sommer, A., Moriggl, R., et al., 2006. Autocrine PDGFR signaling promotes mammary cancer metastasis. J. Clin. Invest., 116(6):1561\u20131570. http:\/\/dx.doi.org\/10.1172\/JCI24652","journal-title":"J. Clin. Invest."},{"issue":"8","key":"271_CR14","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/ijd.12731","volume":"54","author":"K. Kaltalioglu","year":"2015","unstructured":"Kaltalioglu, K., Coskuncevher, S., 2015. A bioactive molecule in a complex wound healing process: platelet-derived growth factor. Int. J. Dermatol., 54(8):972\u2013977. http:\/\/dx.doi.org\/10.1111\/ijd.12731","journal-title":"Int. J. Dermatol."},{"issue":"5","key":"271_CR15","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1073\/pnas.1417660112","volume":"112","author":"J.H. Lee","year":"2015","unstructured":"Lee, J.H., Isayeva, T., Larson, M.R., et al., 2015. Endostatin: a novel inhibitor of androgen receptor function in prostate cancer. Proc. Natl. Acad. Sci. USA, 112(5):1392\u20131397. http:\/\/dx.doi.org\/10.1073\/pnas.1417660112","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"19","key":"271_CR16","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1038\/emboj.2008.178","volume":"27","author":"F. Lehembre","year":"2008","unstructured":"Lehembre, F., Yilmaz, M., Wicki, A., et al., 2008. NCAMinduced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J., 27(19):2603\u20132615. http:\/\/dx.doi.org\/10.1038\/emboj.2008.178","journal-title":"EMBO J."},{"issue":"2","key":"271_CR17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.intimp.2015.02.009","volume":"25","author":"X. Lin","year":"2015","unstructured":"Lin, X., Kong, L.N., Huang, C., et al., 2015. Hesperetin derivative-7 inhibits PDGF-BB-induced hepatic stellate cell activation and proliferation by targeting Wnt\/\u00df-catenin pathway. Int. Immunopharmacol., 25(2):311\u2013320. http:\/\/dx.doi.org\/10.1016\/j.intimp.2015.02.009","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"271_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13613-015-0096-2","volume":"6","author":"J. M\u00e5rtensson","year":"2016","unstructured":"M\u00e5rtensson, J., Jonsson, N., Glassford, N.J., et al., 2016. Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients. Ann. Intens. Care, 6(1): 1\u20139. http:\/\/dx.doi.org\/10.1186\/s13613-016-0108-x","journal-title":"Ann. Intens. Care"},{"issue":"6","key":"271_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"X.M. Meng","year":"2016","unstructured":"Meng, X.M., Nikolic-Paterson, D.J., Lan, H.Y., 2016. TGF-\u00df: the master regulator of fibrosis. Nat. Rev. Nephrol., 12(6): 325\u2013338. http:\/\/dx.doi.org\/10.1038\/nrneph.2016.48","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"271_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1084\/jem.20071412","volume":"205","author":"R. Mori","year":"2008","unstructured":"Mori, R., Shaw, T.J., Martin, P., 2008. Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J. Exp. Med., 205(1):43\u201351. http:\/\/dx.doi.org\/10.1084\/jem.20071412","journal-title":"J. Exp. Med."},{"issue":"1\u20133","key":"271_CR21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejphar.2013.08.013","volume":"718","author":"M. Okada","year":"2013","unstructured":"Okada, M., Suzuki, A., Yamawaki, H., et al., 2013. Levosimendan inhibits interleukin-1\u00df-induced cell migration and MMP-9 secretion in rat cardiac fibroblasts. Eur. J. Pharmacol., 718(1\u20133):332\u2013339. http:\/\/dx.doi.org\/10.1016\/j.ejphar.2013.08.013","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"271_CR22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/SHK.0000000000000427","volume":"44","author":"Y. Peng","year":"2015","unstructured":"Peng, Y., Gao, M., Jiang, Y., et al., 2015. Angiogenesis inhibitor endostatin protects mice with sepsis from multiple organ dysfunction syndrome. Shock, 44(4):357\u2013364. http:\/\/dx.doi.org\/10.1097\/SHK.0000000000000427","journal-title":"Shock"},{"issue":"10","key":"271_CR23","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1074\/jbc.M212927200","volume":"278","author":"S. Reif","year":"2003","unstructured":"Reif, S., Lang, A., Lindquist, J.N., et al., 2003. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type I collagen expression. J. Biol. Chem., 278(10):8083\u20138090. http:\/\/dx.doi.org\/10.1074\/jbc.M212927200","journal-title":"J. Biol. Chem."},{"issue":"3","key":"271_CR24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1631\/jzus.B1200077","volume":"14","author":"H.T. Ren","year":"2013","unstructured":"Ren, H.T., Hu, H., Li, Y., et al., 2013. Endostatin inhibits hypertrophic scarring in a rabbit ear model. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 14(3):224\u2013230. http:\/\/dx.doi.org\/10.1631\/jzus.B1200077","journal-title":"J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.)"},{"key":"271_CR25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.rmed.2016.02.001","volume":"113","author":"L. Richeldi","year":"2016","unstructured":"Richeldi, L., Cottin, V., du Bois, R.M., et al., 2016. Nintedanib in patients with idiopathic pulmonary fibrosis: combined evidence from the TOMORROW and INPULSIS\u00ae trials. Resp. Med., 113:74-79. http:\/\/dx.doi.org\/10.1016\/j.rmed.2016.02.001","journal-title":"Resp. Med."},{"issue":"2","key":"271_CR26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1042\/bj3100585","volume":"310","author":"E. Tan","year":"1995","unstructured":"Tan, E., Qin, H., Kennedy, S., et al., 1995. Platelet-derived growth factors-AA and -BB regulate collagen and collagenase gene expression differentially in human fibroblasts. Biochem. J., 310(2):585\u2013588. http:\/\/dx.doi.org\/10.1042\/bj3100585","journal-title":"Biochem. J."},{"issue":"3","key":"271_CR27","doi-asserted-by":"crossref","first-page":"L348","DOI":"10.1152\/ajplung.00289.2009","volume":"298","author":"K.I. Tanaka","year":"2010","unstructured":"Tanaka, K.I., Ishihara, T., Azuma, A., et al., 2010. Therapeutic effect of lecithinized superoxide dismutase on bleomycininduced pulmonary fibrosis. Am. J. Physiol.-Lung C, 298(3):L348\u2013L360. http:\/\/dx.doi.org\/10.1152\/ajplung.00289.2009","journal-title":"Am. J. Physiol.-Lung C"},{"issue":"3","key":"271_CR28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jcp.10112","volume":"191","author":"P. Tangkijvanich","year":"2002","unstructured":"Tangkijvanich, P., Santiskulvong, C., Melton, A.C., et al., 2002. p38 MAP kinase mediates platelet-derived growth factorstimulated migration of hepatic myofibroblasts. J. Cell. Physiol., 191(3):351\u2013361. http:\/\/dx.doi.org\/10.1002\/jcp.10112","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"271_CR29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.aanat.2008.10.001","volume":"191","author":"S. Tiede","year":"2009","unstructured":"Tiede, S., Ernst, N., Bayat, A., et al., 2009. Basic fibroblast growth factor: a potential new therapeutic tool for the treatment of hypertrophic and keloid scars. Ann. Anat., 191(1):33\u201344. http:\/\/dx.doi.org\/10.1016\/j.aanat.2008.10.001","journal-title":"Ann. Anat."},{"issue":"2","key":"271_CR30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"T. Wynn","year":"2008","unstructured":"Wynn, T., 2008. Cellular and molecular mechanisms of fibrosis. J. Pathol., 214(2):199\u2013210. http:\/\/dx.doi.org\/10.1002\/path.2277","journal-title":"J. Pathol."},{"issue":"136","key":"271_CR31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/scitranslmed.3003421","volume":"4","author":"Y. Yamaguchi","year":"2012","unstructured":"Yamaguchi, Y., Takihara, T., Chambers, R.A., et al., 2012. A peptide derived from endostatin ameliorates organ fibrosis. Sci. Transl. Med., 4(136):136ra71. http:\/\/dx.doi.org\/10.1126\/scitranslmed.3003421","journal-title":"Sci. Transl. Med."}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1631\/jzus.B1700052\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1700052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1700052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T04:53:36Z","timestamp":1524027216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1631\/jzus.B1700052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["271"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b1700052","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Hai-tao REN, http:\/\/orcid.org\/0000-0003-2588-9523","URL":"http","order":0,"name":"name","label":"Hai-tao REN","group":{"name":"orcid","label":"ORCID"}},{"value":"doi:10.1631\/jzus.B1200077","URL":"http:\/\/www.jzus.zju.edu.cn\/article.php?doi=10.1631\/jzus.B1200077","order":0,"name":"name","label":"Endostatin inhibits hypertrophic scarring...","group":{"name":"name","label":"Similar articles"}},{"value":"2017-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-20","order":2,"name":"crosschecked","label":"Crosschecked","group":{"name":"publication_history","label":"Publication History"}},{"value":"Article","order":0,"name":"content_type","group":{"name":"content_type","label":"Content Type"}},{"value":"\u00a9 Zhejiang University and Springer-Verlag GmbH Germany 2017","order":0,"name":"copyright","group":{"name":"copyright","label":"Copyright"}}]}}